RxDoctor Payments DataLook up a doctor →

Karbinal: payments to doctors

Payments that named Karbinal as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$64K
Providers
1,826
Transactions
3,525
Average per transaction
$18

The per-transaction average — $18 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 1,826 providers the average total is $35, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Aytu Biopharma, Inc.$27,13042.3%
AYTU Biopharma, Inc.$25,89140.4%
Neos Therapeutics, LP$7,59711.9%
Aytu Bioscience, Inc$3,4825.4%
← All drugs & devices